Levothyroxine Sodium Tablet
Product Images NDC 82804-290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 82804-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)
Chemical structure diagram of levothyroxine sodium showing its molecular arrangement with iodine atoms, hydroxyl group, amine group, and sodium carboxylate with hydration indicated by xH2O.*
FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

FDA Label Image

82804-290-30 (Image 01)

82804-290-30 (Image 01)
Packaging label for Levothyroxine Sodium 100 mcg (0.1 mg) tablets, with a quantity of 30 tablets. The label shows the product as manufactured by Lupin Limited in India and packaged by Proficient Rx LP, Thousand Oaks, CA. The tablets are described as round, yellow, scored, and debossed with L20 on one side. The label includes multiple instances of the NDC 82804-290-30 and various lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.